High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).

Vassallo, E; Di Noto, L; Palmeri, L; Vaglica, M; Pancera, G; Palmeri, S

Vassallo, E; Di Noto, L; Palmeri, L; Vaglica, M; Pancera, G; Palmeri, S.

Leuk Lymphoma ; 47(8): 1686-7, 2006 Aug.

Article in En | MEDLINE | ID: mdl-16966287

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lymphoma, Non-Hodgkin/drug therapy; Rectal Neoplasms/drug therapy; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide/therapeutic use; Doxorubicin/therapeutic use; Female; Humans; Middle Aged; Prednisolone/therapeutic use; Rituximab; Treatment Outcome; Vincristine/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rectal Neoplasms / Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2006 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links